摘要
对咪唑立宾的结晶工艺进行优化,探究了抗溶剂种类、溶液初始浓度、抗溶剂滴加速度及抗溶剂加量对咪唑立宾结晶纯度、堆密度、收率和产品稳定性的影响。确定最佳结晶工艺为:以乙醇为抗溶剂、溶液初始浓度0.7 g·mL^-1、抗溶剂滴加速度5 BV·h^-1、抗溶剂加量为咪唑立宾水溶液体积的12倍(12 BV)。该结晶工艺所得产品纯度高、杂质少、堆密度较大、稳定性好,适合工业化生产,有利于长期储存和制剂分装。
We optimized the crystallization process of Mizoribine,and investigated the effects of anti-solvent types,initial concentration of solution,dropping rate of anti-solvent,and anti-solvent dosage on the purity,bulk density,yield,and stability of Mizoribine crystal.The optimal crystallization process is determined as follows:ethanol is used as the anti-solvent,the initial concentration of solution is 0.7 g·mL^-1,the dropping rate of anti-solvent is 5 BV·h^-1,and the anti-solvent dosage is 12 times(12 BV)the volume of Mizoribine aqueous solution.The obtained product has high purity,low impurity,large bulk density,and good stability,and this crystallization process is suitable for industrial production and is beneficial to long-term storage and preparation packaging.
作者
程曜峰
冷凤
孙丙林
张炜
张雪霞
CHENG Yaofeng;LENG Feng;SUN Binglin;ZHANG Wei;ZHANG Xuexia(NCPC New Drug Research & Development Co.,Ltd.,National Engineering Research Center of Microbial Medicine,Hebei Industry Microbial Metabolic Engineering & Technology Research Center,Shijiazhuang 050015,China;NCPC Huasheng Co.,Ltd.,Shijiazhuang 050015,China)
出处
《化学与生物工程》
CAS
2020年第11期61-63,共3页
Chemistry & Bioengineering
基金
河北省科技研发平台建设专项(199676154H)。
关键词
咪唑立宾
结晶
稳定性
堆密度
Mizoribine
crystallization
stability
bulk density